nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—Benzyl Benzoate—Toremifene—breast cancer	0.117	0.614	CrCrCtD
Fosphenytoin—CYP3A4—breast cancer	0.109	0.534	CbGaD
Fosphenytoin—ALB—breast cancer	0.0947	0.466	CbGaD
Fosphenytoin—Benzyl Benzoate—Tamoxifen—breast cancer	0.0734	0.386	CrCrCtD
Fosphenytoin—CYP2B6—Thiotepa—breast cancer	0.0321	0.0804	CbGbCtD
Fosphenytoin—CYP2C9—Anastrozole—breast cancer	0.0224	0.0561	CbGbCtD
Fosphenytoin—CYP2B6—Raloxifene—breast cancer	0.0214	0.0537	CbGbCtD
Fosphenytoin—CYP2C8—Lapatinib—breast cancer	0.0214	0.0536	CbGbCtD
Fosphenytoin—CYP2C19—Lapatinib—breast cancer	0.0179	0.045	CbGbCtD
Fosphenytoin—CYP3A4—Exemestane—breast cancer	0.0172	0.043	CbGbCtD
Fosphenytoin—CYP2C9—Idarubicin—breast cancer	0.0169	0.0425	CbGbCtD
Fosphenytoin—CYP2C8—Raloxifene—breast cancer	0.0162	0.0406	CbGbCtD
Fosphenytoin—CYP3A4—Letrozole—breast cancer	0.0146	0.0366	CbGbCtD
Fosphenytoin—CYP2B6—Tamoxifen—breast cancer	0.0141	0.0355	CbGbCtD
Fosphenytoin—CYP3A4—Anastrozole—breast cancer	0.013	0.0326	CbGbCtD
Fosphenytoin—CYP3A4—Toremifene—breast cancer	0.0119	0.0298	CbGbCtD
Fosphenytoin—CYP3A4—Fulvestrant—breast cancer	0.0111	0.0277	CbGbCtD
Fosphenytoin—CYP2B6—Irinotecan—breast cancer	0.0109	0.0272	CbGbCtD
Fosphenytoin—CYP2C8—Tamoxifen—breast cancer	0.0107	0.0269	CbGbCtD
Fosphenytoin—ALB—Irinotecan—breast cancer	0.0106	0.0267	CbGbCtD
Fosphenytoin—ALB—Fluorouracil—breast cancer	0.0102	0.0256	CbGbCtD
Fosphenytoin—CYP3A4—Thiotepa—breast cancer	0.00986	0.0247	CbGbCtD
Fosphenytoin—CYP2C9—Capecitabine—breast cancer	0.00929	0.0233	CbGbCtD
Fosphenytoin—CYP3A4—Ixabepilone—breast cancer	0.00901	0.0226	CbGbCtD
Fosphenytoin—CYP2C19—Tamoxifen—breast cancer	0.00899	0.0225	CbGbCtD
Fosphenytoin—CYP3A4—Lapatinib—breast cancer	0.00868	0.0217	CbGbCtD
Fosphenytoin—CYP2C8—Paclitaxel—breast cancer	0.00834	0.0209	CbGbCtD
Fosphenytoin—CYP2C8—Fluorouracil—breast cancer	0.00789	0.0198	CbGbCtD
Fosphenytoin—CYP2C9—Tamoxifen—breast cancer	0.00747	0.0187	CbGbCtD
Fosphenytoin—CYP3A4—Raloxifene—breast cancer	0.00658	0.0165	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—breast cancer	0.00593	0.0149	CbGbCtD
Fosphenytoin—CYP2C9—Paclitaxel—breast cancer	0.00582	0.0146	CbGbCtD
Fosphenytoin—ALB—Methotrexate—breast cancer	0.00563	0.0141	CbGbCtD
Fosphenytoin—CYP2C9—Fluorouracil—breast cancer	0.00551	0.0138	CbGbCtD
Fosphenytoin—CYP3A4—Vinorelbine—breast cancer	0.00481	0.0121	CbGbCtD
Fosphenytoin—CYP3A4—Tamoxifen—breast cancer	0.00434	0.0109	CbGbCtD
Fosphenytoin—CYP3A4—Mitoxantrone—breast cancer	0.00424	0.0106	CbGbCtD
Fosphenytoin—CYP3A4—Paclitaxel—breast cancer	0.00338	0.00848	CbGbCtD
Fosphenytoin—CYP3A4—Irinotecan—breast cancer	0.00334	0.00836	CbGbCtD
Fosphenytoin—CYP3A4—Vinblastine—breast cancer	0.00297	0.00743	CbGbCtD
Fosphenytoin—CYP3A4—Docetaxel—breast cancer	0.00244	0.00613	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—breast cancer	0.00182	0.00457	CbGbCtD
Fosphenytoin—Phenylbutazone—PTGS1—breast cancer	0.000138	0.27	CrCbGaD
Fosphenytoin—Phenylbutazone—CYP3A4—breast cancer	8.04e-05	0.157	CrCbGaD
Fosphenytoin—Phenylbutazone—PTGS2—breast cancer	7.87e-05	0.154	CrCbGaD
Fosphenytoin—Modafinil—CYP3A4—breast cancer	6.3e-05	0.123	CrCbGaD
Fosphenytoin—Phenytoin—CYP3A4—breast cancer	5.58e-05	0.109	CrCbGaD
Fosphenytoin—Phenytoin—ALB—breast cancer	4.87e-05	0.0954	CrCbGaD
Fosphenytoin—Phenytoin—ABCB1—breast cancer	4.65e-05	0.091	CrCbGaD
Fosphenytoin—Diarrhoea—Mitoxantrone—breast cancer	3.43e-05	0.000227	CcSEcCtD
Fosphenytoin—Dry mouth—Capecitabine—breast cancer	3.43e-05	0.000227	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—breast cancer	3.42e-05	0.000226	CcSEcCtD
Fosphenytoin—Shock—Docetaxel—breast cancer	3.41e-05	0.000226	CcSEcCtD
Fosphenytoin—Pruritus—Fluorouracil—breast cancer	3.4e-05	0.000225	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Docetaxel—breast cancer	3.4e-05	0.000225	CcSEcCtD
Fosphenytoin—Confusional state—Capecitabine—breast cancer	3.39e-05	0.000224	CcSEcCtD
Fosphenytoin—Tachycardia—Docetaxel—breast cancer	3.39e-05	0.000224	CcSEcCtD
Fosphenytoin—Feeling abnormal—Paclitaxel—breast cancer	3.37e-05	0.000223	CcSEcCtD
Fosphenytoin—Bradycardia—Epirubicin—breast cancer	3.35e-05	0.000222	CcSEcCtD
Fosphenytoin—Diarrhoea—Gemcitabine—breast cancer	3.35e-05	0.000221	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—breast cancer	3.34e-05	0.000221	CcSEcCtD
Fosphenytoin—Infection—Capecitabine—breast cancer	3.34e-05	0.000221	CcSEcCtD
Fosphenytoin—Dizziness—Irinotecan—breast cancer	3.32e-05	0.00022	CcSEcCtD
Fosphenytoin—Anorexia—Docetaxel—breast cancer	3.31e-05	0.000219	CcSEcCtD
Fosphenytoin—Shock—Capecitabine—breast cancer	3.31e-05	0.000219	CcSEcCtD
Fosphenytoin—Rhinitis—Epirubicin—breast cancer	3.3e-05	0.000218	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—breast cancer	3.3e-05	0.000218	CcSEcCtD
Fosphenytoin—Diarrhoea—Fluorouracil—breast cancer	3.29e-05	0.000218	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Capecitabine—breast cancer	3.29e-05	0.000218	CcSEcCtD
Fosphenytoin—Tinnitus—Methotrexate—breast cancer	3.28e-05	0.000217	CcSEcCtD
Fosphenytoin—Tachycardia—Capecitabine—breast cancer	3.28e-05	0.000217	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Epirubicin—breast cancer	3.28e-05	0.000217	CcSEcCtD
Fosphenytoin—Pharyngitis—Epirubicin—breast cancer	3.27e-05	0.000216	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—breast cancer	3.26e-05	0.000215	CcSEcCtD
Fosphenytoin—Urticaria—Paclitaxel—breast cancer	3.25e-05	0.000215	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Capecitabine—breast cancer	3.25e-05	0.000215	CcSEcCtD
Fosphenytoin—Hypotension—Docetaxel—breast cancer	3.24e-05	0.000214	CcSEcCtD
Fosphenytoin—Body temperature increased—Paclitaxel—breast cancer	3.24e-05	0.000214	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—breast cancer	3.2e-05	0.000212	CcSEcCtD
Fosphenytoin—Anorexia—Capecitabine—breast cancer	3.2e-05	0.000212	CcSEcCtD
Fosphenytoin—Vomiting—Mitoxantrone—breast cancer	3.19e-05	0.000211	CcSEcCtD
Fosphenytoin—Vomiting—Irinotecan—breast cancer	3.19e-05	0.000211	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—breast cancer	3.19e-05	0.000211	CcSEcCtD
Fosphenytoin—Dizziness—Fluorouracil—breast cancer	3.18e-05	0.00021	CcSEcCtD
Fosphenytoin—Rash—Mitoxantrone—breast cancer	3.17e-05	0.000209	CcSEcCtD
Fosphenytoin—Rash—Irinotecan—breast cancer	3.17e-05	0.000209	CcSEcCtD
Fosphenytoin—Dermatitis—Mitoxantrone—breast cancer	3.16e-05	0.000209	CcSEcCtD
Fosphenytoin—Dermatitis—Irinotecan—breast cancer	3.16e-05	0.000209	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Docetaxel—breast cancer	3.16e-05	0.000209	CcSEcCtD
Fosphenytoin—Chills—Methotrexate—breast cancer	3.16e-05	0.000209	CcSEcCtD
Fosphenytoin—Headache—Irinotecan—breast cancer	3.14e-05	0.000208	CcSEcCtD
Fosphenytoin—Headache—Mitoxantrone—breast cancer	3.14e-05	0.000208	CcSEcCtD
Fosphenytoin—Hypotension—Capecitabine—breast cancer	3.14e-05	0.000208	CcSEcCtD
Fosphenytoin—Insomnia—Docetaxel—breast cancer	3.14e-05	0.000208	CcSEcCtD
Fosphenytoin—Paraesthesia—Docetaxel—breast cancer	3.12e-05	0.000206	CcSEcCtD
Fosphenytoin—Vomiting—Gemcitabine—breast cancer	3.11e-05	0.000206	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—breast cancer	3.1e-05	0.000205	CcSEcCtD
Fosphenytoin—Dyspnoea—Docetaxel—breast cancer	3.09e-05	0.000205	CcSEcCtD
Fosphenytoin—Somnolence—Docetaxel—breast cancer	3.09e-05	0.000204	CcSEcCtD
Fosphenytoin—Rash—Gemcitabine—breast cancer	3.08e-05	0.000204	CcSEcCtD
Fosphenytoin—Dermatitis—Gemcitabine—breast cancer	3.08e-05	0.000204	CcSEcCtD
Fosphenytoin—Tinnitus—Epirubicin—breast cancer	3.07e-05	0.000203	CcSEcCtD
Fosphenytoin—Headache—Gemcitabine—breast cancer	3.06e-05	0.000203	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Capecitabine—breast cancer	3.06e-05	0.000202	CcSEcCtD
Fosphenytoin—Vomiting—Fluorouracil—breast cancer	3.06e-05	0.000202	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—breast cancer	3.06e-05	0.000202	CcSEcCtD
Fosphenytoin—Dyspepsia—Docetaxel—breast cancer	3.05e-05	0.000202	CcSEcCtD
Fosphenytoin—Insomnia—Capecitabine—breast cancer	3.04e-05	0.000201	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—breast cancer	3.03e-05	0.000201	CcSEcCtD
Fosphenytoin—Rash—Fluorouracil—breast cancer	3.03e-05	0.000201	CcSEcCtD
Fosphenytoin—Dermatitis—Fluorouracil—breast cancer	3.03e-05	0.0002	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—breast cancer	3.03e-05	0.0002	CcSEcCtD
Fosphenytoin—Paraesthesia—Capecitabine—breast cancer	3.02e-05	0.0002	CcSEcCtD
Fosphenytoin—Decreased appetite—Docetaxel—breast cancer	3.02e-05	0.0002	CcSEcCtD
Fosphenytoin—Headache—Fluorouracil—breast cancer	3.01e-05	0.000199	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—breast cancer	3e-05	0.000198	CcSEcCtD
Fosphenytoin—Dyspnoea—Capecitabine—breast cancer	3e-05	0.000198	CcSEcCtD
Fosphenytoin—Nausea—Irinotecan—breast cancer	2.98e-05	0.000197	CcSEcCtD
Fosphenytoin—Nausea—Mitoxantrone—breast cancer	2.98e-05	0.000197	CcSEcCtD
Fosphenytoin—Constipation—Docetaxel—breast cancer	2.97e-05	0.000196	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—breast cancer	2.96e-05	0.000196	CcSEcCtD
Fosphenytoin—Dyspepsia—Capecitabine—breast cancer	2.96e-05	0.000196	CcSEcCtD
Fosphenytoin—Chills—Epirubicin—breast cancer	2.96e-05	0.000196	CcSEcCtD
Fosphenytoin—Asthenia—Paclitaxel—breast cancer	2.94e-05	0.000194	CcSEcCtD
Fosphenytoin—Decreased appetite—Capecitabine—breast cancer	2.92e-05	0.000193	CcSEcCtD
Fosphenytoin—Nausea—Gemcitabine—breast cancer	2.9e-05	0.000192	CcSEcCtD
Fosphenytoin—Pruritus—Paclitaxel—breast cancer	2.9e-05	0.000192	CcSEcCtD
Fosphenytoin—Constipation—Capecitabine—breast cancer	2.87e-05	0.00019	CcSEcCtD
Fosphenytoin—Feeling abnormal—Docetaxel—breast cancer	2.86e-05	0.000189	CcSEcCtD
Fosphenytoin—Nausea—Fluorouracil—breast cancer	2.86e-05	0.000189	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—breast cancer	2.84e-05	0.000188	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—breast cancer	2.84e-05	0.000188	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—breast cancer	2.83e-05	0.000187	CcSEcCtD
Fosphenytoin—Flatulence—Epirubicin—breast cancer	2.83e-05	0.000187	CcSEcCtD
Fosphenytoin—Tension—Epirubicin—breast cancer	2.81e-05	0.000186	CcSEcCtD
Fosphenytoin—Dysgeusia—Epirubicin—breast cancer	2.81e-05	0.000186	CcSEcCtD
Fosphenytoin—Diarrhoea—Paclitaxel—breast cancer	2.8e-05	0.000185	CcSEcCtD
Fosphenytoin—Nervousness—Epirubicin—breast cancer	2.79e-05	0.000184	CcSEcCtD
Fosphenytoin—Back pain—Epirubicin—breast cancer	2.77e-05	0.000183	CcSEcCtD
Fosphenytoin—Feeling abnormal—Capecitabine—breast cancer	2.77e-05	0.000183	CcSEcCtD
Fosphenytoin—Malaise—Methotrexate—breast cancer	2.76e-05	0.000183	CcSEcCtD
Fosphenytoin—Muscle spasms—Epirubicin—breast cancer	2.76e-05	0.000182	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—breast cancer	2.75e-05	0.000182	CcSEcCtD
Fosphenytoin—Body temperature increased—Docetaxel—breast cancer	2.74e-05	0.000181	CcSEcCtD
Fosphenytoin—Leukopenia—Methotrexate—breast cancer	2.74e-05	0.000181	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—breast cancer	2.74e-05	0.000181	CcSEcCtD
Fosphenytoin—Dizziness—Paclitaxel—breast cancer	2.71e-05	0.000179	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—breast cancer	2.67e-05	0.000177	CcSEcCtD
Fosphenytoin—Urticaria—Capecitabine—breast cancer	2.67e-05	0.000177	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Epirubicin—breast cancer	2.66e-05	0.000176	CcSEcCtD
Fosphenytoin—Body temperature increased—Capecitabine—breast cancer	2.66e-05	0.000176	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—breast cancer	2.66e-05	0.000176	CcSEcCtD
Fosphenytoin—Anaemia—Epirubicin—breast cancer	2.65e-05	0.000175	CcSEcCtD
Fosphenytoin—Agitation—Epirubicin—breast cancer	2.64e-05	0.000174	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—breast cancer	2.61e-05	0.000173	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—breast cancer	2.61e-05	0.000173	CcSEcCtD
Fosphenytoin—Arthralgia—Methotrexate—breast cancer	2.61e-05	0.000173	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—breast cancer	2.6e-05	0.000172	CcSEcCtD
Fosphenytoin—Vomiting—Paclitaxel—breast cancer	2.6e-05	0.000172	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—breast cancer	2.6e-05	0.000172	CcSEcCtD
Fosphenytoin—Malaise—Epirubicin—breast cancer	2.59e-05	0.000171	CcSEcCtD
Fosphenytoin—Rash—Paclitaxel—breast cancer	2.58e-05	0.000171	CcSEcCtD
Fosphenytoin—Dermatitis—Paclitaxel—breast cancer	2.58e-05	0.000171	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—breast cancer	2.58e-05	0.00017	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—breast cancer	2.58e-05	0.00017	CcSEcCtD
Fosphenytoin—Vertigo—Epirubicin—breast cancer	2.58e-05	0.00017	CcSEcCtD
Fosphenytoin—Syncope—Epirubicin—breast cancer	2.57e-05	0.00017	CcSEcCtD
Fosphenytoin—Leukopenia—Epirubicin—breast cancer	2.57e-05	0.00017	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—breast cancer	2.57e-05	0.00017	CcSEcCtD
Fosphenytoin—Headache—Paclitaxel—breast cancer	2.56e-05	0.00017	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—breast cancer	2.55e-05	0.000169	CcSEcCtD
Fosphenytoin—Palpitations—Epirubicin—breast cancer	2.53e-05	0.000168	CcSEcCtD
Fosphenytoin—Confusional state—Methotrexate—breast cancer	2.52e-05	0.000167	CcSEcCtD
Fosphenytoin—Loss of consciousness—Epirubicin—breast cancer	2.52e-05	0.000167	CcSEcCtD
Fosphenytoin—Cough—Epirubicin—breast cancer	2.5e-05	0.000166	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—breast cancer	2.5e-05	0.000165	CcSEcCtD
Fosphenytoin—Asthenia—Docetaxel—breast cancer	2.49e-05	0.000165	CcSEcCtD
Fosphenytoin—Convulsion—Epirubicin—breast cancer	2.48e-05	0.000164	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—breast cancer	2.48e-05	0.000164	CcSEcCtD
Fosphenytoin—Hypertension—Epirubicin—breast cancer	2.48e-05	0.000164	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—breast cancer	2.46e-05	0.000163	CcSEcCtD
Fosphenytoin—Pruritus—Docetaxel—breast cancer	2.46e-05	0.000162	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—breast cancer	2.45e-05	0.000162	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—breast cancer	2.45e-05	0.000162	CcSEcCtD
Fosphenytoin—Arthralgia—Epirubicin—breast cancer	2.44e-05	0.000161	CcSEcCtD
Fosphenytoin—Myalgia—Epirubicin—breast cancer	2.44e-05	0.000161	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—breast cancer	2.44e-05	0.000161	CcSEcCtD
Fosphenytoin—Nausea—Paclitaxel—breast cancer	2.43e-05	0.000161	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—breast cancer	2.42e-05	0.00016	CcSEcCtD
Fosphenytoin—Discomfort—Epirubicin—breast cancer	2.41e-05	0.00016	CcSEcCtD
Fosphenytoin—Asthenia—Capecitabine—breast cancer	2.41e-05	0.000159	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—breast cancer	2.39e-05	0.000158	CcSEcCtD
Fosphenytoin—Dry mouth—Epirubicin—breast cancer	2.39e-05	0.000158	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—breast cancer	2.38e-05	0.000158	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—breast cancer	2.38e-05	0.000158	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—breast cancer	2.38e-05	0.000157	CcSEcCtD
Fosphenytoin—Pruritus—Capecitabine—breast cancer	2.38e-05	0.000157	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—breast cancer	2.38e-05	0.000157	CcSEcCtD
Fosphenytoin—Diarrhoea—Docetaxel—breast cancer	2.37e-05	0.000157	CcSEcCtD
Fosphenytoin—Confusional state—Epirubicin—breast cancer	2.36e-05	0.000156	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—breast cancer	2.35e-05	0.000155	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Epirubicin—breast cancer	2.34e-05	0.000155	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—breast cancer	2.34e-05	0.000155	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—breast cancer	2.33e-05	0.000154	CcSEcCtD
Fosphenytoin—Infection—Epirubicin—breast cancer	2.33e-05	0.000154	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—breast cancer	2.32e-05	0.000153	CcSEcCtD
Fosphenytoin—Shock—Epirubicin—breast cancer	2.3e-05	0.000152	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—breast cancer	2.3e-05	0.000152	CcSEcCtD
Fosphenytoin—Diarrhoea—Capecitabine—breast cancer	2.3e-05	0.000152	CcSEcCtD
Fosphenytoin—Dizziness—Docetaxel—breast cancer	2.29e-05	0.000152	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Epirubicin—breast cancer	2.29e-05	0.000152	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—breast cancer	2.29e-05	0.000152	CcSEcCtD
Fosphenytoin—Tachycardia—Epirubicin—breast cancer	2.28e-05	0.000151	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—breast cancer	2.28e-05	0.000151	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Epirubicin—breast cancer	2.26e-05	0.00015	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—breast cancer	2.26e-05	0.00015	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—breast cancer	2.26e-05	0.000149	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—breast cancer	2.26e-05	0.000149	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—breast cancer	2.25e-05	0.000149	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—breast cancer	2.23e-05	0.000148	CcSEcCtD
Fosphenytoin—Anorexia—Epirubicin—breast cancer	2.23e-05	0.000148	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—breast cancer	2.23e-05	0.000147	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—breast cancer	2.22e-05	0.000147	CcSEcCtD
Fosphenytoin—Dizziness—Capecitabine—breast cancer	2.22e-05	0.000147	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—breast cancer	2.21e-05	0.000146	CcSEcCtD
Fosphenytoin—Vomiting—Docetaxel—breast cancer	2.21e-05	0.000146	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—breast cancer	2.2e-05	0.000146	CcSEcCtD
Fosphenytoin—Rash—Docetaxel—breast cancer	2.19e-05	0.000145	CcSEcCtD
Fosphenytoin—Hypotension—Epirubicin—breast cancer	2.19e-05	0.000145	CcSEcCtD
Fosphenytoin—Dermatitis—Docetaxel—breast cancer	2.19e-05	0.000145	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—breast cancer	2.18e-05	0.000144	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—breast cancer	2.17e-05	0.000144	CcSEcCtD
Fosphenytoin—Headache—Docetaxel—breast cancer	2.17e-05	0.000144	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—breast cancer	2.17e-05	0.000143	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—breast cancer	2.15e-05	0.000142	CcSEcCtD
Fosphenytoin—Vomiting—Capecitabine—breast cancer	2.14e-05	0.000141	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Epirubicin—breast cancer	2.13e-05	0.000141	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—breast cancer	2.13e-05	0.000141	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—breast cancer	2.12e-05	0.00014	CcSEcCtD
Fosphenytoin—Rash—Capecitabine—breast cancer	2.12e-05	0.00014	CcSEcCtD
Fosphenytoin—Insomnia—Epirubicin—breast cancer	2.12e-05	0.00014	CcSEcCtD
Fosphenytoin—Dermatitis—Capecitabine—breast cancer	2.12e-05	0.00014	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—breast cancer	2.11e-05	0.00014	CcSEcCtD
Fosphenytoin—Headache—Capecitabine—breast cancer	2.1e-05	0.000139	CcSEcCtD
Fosphenytoin—Paraesthesia—Epirubicin—breast cancer	2.1e-05	0.000139	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—breast cancer	2.09e-05	0.000138	CcSEcCtD
Fosphenytoin—Dyspnoea—Epirubicin—breast cancer	2.09e-05	0.000138	CcSEcCtD
Fosphenytoin—Somnolence—Epirubicin—breast cancer	2.08e-05	0.000138	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—breast cancer	2.06e-05	0.000137	CcSEcCtD
Fosphenytoin—Nausea—Docetaxel—breast cancer	2.06e-05	0.000136	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—breast cancer	2.06e-05	0.000136	CcSEcCtD
Fosphenytoin—Dyspepsia—Epirubicin—breast cancer	2.06e-05	0.000136	CcSEcCtD
Fosphenytoin—Decreased appetite—Epirubicin—breast cancer	2.03e-05	0.000135	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—breast cancer	2.02e-05	0.000134	CcSEcCtD
Fosphenytoin—Constipation—Epirubicin—breast cancer	2e-05	0.000132	CcSEcCtD
Fosphenytoin—Nausea—Capecitabine—breast cancer	2e-05	0.000132	CcSEcCtD
Fosphenytoin—Urticaria—Methotrexate—breast cancer	1.99e-05	0.000131	CcSEcCtD
Fosphenytoin—Body temperature increased—Methotrexate—breast cancer	1.98e-05	0.000131	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.97e-05	0.000131	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—breast cancer	1.96e-05	0.00013	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—breast cancer	1.94e-05	0.000129	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—breast cancer	1.93e-05	0.000128	CcSEcCtD
Fosphenytoin—Feeling abnormal—Epirubicin—breast cancer	1.93e-05	0.000128	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—breast cancer	1.93e-05	0.000127	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—breast cancer	1.91e-05	0.000126	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—breast cancer	1.88e-05	0.000125	CcSEcCtD
Fosphenytoin—Urticaria—Epirubicin—breast cancer	1.86e-05	0.000123	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—breast cancer	1.85e-05	0.000122	CcSEcCtD
Fosphenytoin—Body temperature increased—Epirubicin—breast cancer	1.85e-05	0.000122	CcSEcCtD
Fosphenytoin—Asthenia—Methotrexate—breast cancer	1.79e-05	0.000119	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—breast cancer	1.78e-05	0.000118	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—breast cancer	1.77e-05	0.000117	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—breast cancer	1.72e-05	0.000114	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—breast cancer	1.71e-05	0.000113	CcSEcCtD
Fosphenytoin—Diarrhoea—Methotrexate—breast cancer	1.71e-05	0.000113	CcSEcCtD
Fosphenytoin—Asthenia—Epirubicin—breast cancer	1.68e-05	0.000111	CcSEcCtD
Fosphenytoin—Pruritus—Epirubicin—breast cancer	1.66e-05	0.00011	CcSEcCtD
Fosphenytoin—Dizziness—Methotrexate—breast cancer	1.65e-05	0.000109	CcSEcCtD
Fosphenytoin—Diarrhoea—Epirubicin—breast cancer	1.6e-05	0.000106	CcSEcCtD
Fosphenytoin—Vomiting—Methotrexate—breast cancer	1.59e-05	0.000105	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—breast cancer	1.58e-05	0.000104	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—breast cancer	1.58e-05	0.000104	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—breast cancer	1.57e-05	0.000104	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—breast cancer	1.55e-05	0.000103	CcSEcCtD
Fosphenytoin—Dizziness—Epirubicin—breast cancer	1.55e-05	0.000102	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—breast cancer	1.53e-05	0.000101	CcSEcCtD
Fosphenytoin—Vomiting—Epirubicin—breast cancer	1.49e-05	9.84e-05	CcSEcCtD
Fosphenytoin—Nausea—Methotrexate—breast cancer	1.49e-05	9.83e-05	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—breast cancer	1.48e-05	9.8e-05	CcSEcCtD
Fosphenytoin—Rash—Epirubicin—breast cancer	1.48e-05	9.76e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Epirubicin—breast cancer	1.47e-05	9.75e-05	CcSEcCtD
Fosphenytoin—Headache—Epirubicin—breast cancer	1.47e-05	9.7e-05	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—breast cancer	1.43e-05	9.47e-05	CcSEcCtD
Fosphenytoin—Nausea—Epirubicin—breast cancer	1.39e-05	9.2e-05	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—breast cancer	1.38e-05	9.11e-05	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—breast cancer	1.37e-05	9.03e-05	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—breast cancer	1.36e-05	9.02e-05	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—breast cancer	1.36e-05	8.97e-05	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—breast cancer	1.29e-05	8.51e-05	CcSEcCtD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.64e-06	8.3e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—COMT—breast cancer	4.64e-06	8.3e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP2D6—breast cancer	4.62e-06	8.28e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTP1—breast cancer	4.61e-06	8.26e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IL2—breast cancer	4.6e-06	8.24e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HMMR—breast cancer	4.59e-06	8.22e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA3—breast cancer	4.59e-06	8.22e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCC1—breast cancer	4.59e-06	8.22e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ACHE—breast cancer	4.59e-06	8.22e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTT1—breast cancer	4.59e-06	8.22e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.59e-06	8.21e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP3A4—breast cancer	4.57e-06	8.18e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.56e-06	8.17e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—HMOX1—breast cancer	4.55e-06	8.15e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.54e-06	8.14e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP3A4—breast cancer	4.54e-06	8.13e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ITPR1—breast cancer	4.54e-06	8.13e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NCOA2—breast cancer	4.54e-06	8.13e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.52e-06	8.09e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP1B1—breast cancer	4.49e-06	8.04e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP1B1—breast cancer	4.46e-06	8e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.44e-06	7.96e-05	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	4.44e-06	7.95e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—HSP90AA1—breast cancer	4.4e-06	7.89e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—FASN—breast cancer	4.4e-06	7.88e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—BCHE—breast cancer	4.38e-06	7.85e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—HSP90AA1—breast cancer	4.38e-06	7.84e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ABCB1—breast cancer	4.37e-06	7.82e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP17A1—breast cancer	4.34e-06	7.78e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SLC5A5—breast cancer	4.33e-06	7.75e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ENO1—breast cancer	4.3e-06	7.7e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTGS1—breast cancer	4.3e-06	7.7e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—TYMS—breast cancer	4.29e-06	7.68e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NCOA1—breast cancer	4.28e-06	7.67e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.28e-06	7.67e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NCOA1—breast cancer	4.26e-06	7.63e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PLA2G4A—breast cancer	4.24e-06	7.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NCOR1—breast cancer	4.24e-06	7.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GSTM1—breast cancer	4.24e-06	7.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.23e-06	7.57e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP19A1—breast cancer	4.22e-06	7.56e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—STK11—breast cancer	4.22e-06	7.56e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP2D6—breast cancer	4.21e-06	7.55e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP19A1—breast cancer	4.2e-06	7.52e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—STK11—breast cancer	4.2e-06	7.52e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CA9—breast cancer	4.2e-06	7.52e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA4—breast cancer	4.2e-06	7.52e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SLC2A1—breast cancer	4.18e-06	7.49e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NQO1—breast cancer	4.18e-06	7.49e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NCOA2—breast cancer	4.14e-06	7.41e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.09e-06	7.33e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA2—breast cancer	4.09e-06	7.32e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GPX2—breast cancer	4.09e-06	7.32e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP3A4—breast cancer	4.08e-06	7.3e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GPX1—breast cancer	4.06e-06	7.27e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.06e-06	7.26e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SULT1A1—breast cancer	4.04e-06	7.23e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GPX4—breast cancer	4.04e-06	7.23e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP1A1—breast cancer	4.02e-06	7.2e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SRC—breast cancer	4.01e-06	7.19e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—FASN—breast cancer	4.01e-06	7.19e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP1B1—breast cancer	4.01e-06	7.18e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—BCHE—breast cancer	4e-06	7.16e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ERCC2—breast cancer	3.99e-06	7.14e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.96e-06	7.1e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SLC5A5—breast cancer	3.95e-06	7.07e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTA1—breast cancer	3.94e-06	7.07e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—IDH1—breast cancer	3.94e-06	7.07e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.94e-06	7.06e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.93e-06	7.04e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—COMT—breast cancer	3.92e-06	7.03e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—VEGFA—breast cancer	3.91e-06	7e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTP1—breast cancer	3.91e-06	7e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—COMT—breast cancer	3.9e-06	6.99e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NAT2—breast cancer	3.9e-06	6.99e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTP1—breast cancer	3.88e-06	6.96e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—HMOX1—breast cancer	3.85e-06	6.9e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ITPR1—breast cancer	3.84e-06	6.88e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—HMOX1—breast cancer	3.83e-06	6.86e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NCOA1—breast cancer	3.82e-06	6.85e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ITPR1—breast cancer	3.82e-06	6.85e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NQO1—breast cancer	3.81e-06	6.83e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SLC2A1—breast cancer	3.81e-06	6.83e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—STK11—breast cancer	3.77e-06	6.75e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP19A1—breast cancer	3.77e-06	6.75e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—MTHFR—breast cancer	3.75e-06	6.71e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.73e-06	6.69e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP3A4—breast cancer	3.72e-06	6.66e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.7e-06	6.62e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—MAPK3—breast cancer	3.7e-06	6.62e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ABCB1—breast cancer	3.7e-06	6.62e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ABCB1—breast cancer	3.68e-06	6.59e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP1B1—breast cancer	3.65e-06	6.55e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—TYMS—breast cancer	3.63e-06	6.5e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—TYMS—breast cancer	3.61e-06	6.47e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NCOR1—breast cancer	3.59e-06	6.43e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GSTM1—breast cancer	3.59e-06	6.43e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PLA2G4A—breast cancer	3.59e-06	6.43e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TGFB1—breast cancer	3.59e-06	6.43e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.58e-06	6.42e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PLA2G4A—breast cancer	3.57e-06	6.39e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NCOR1—breast cancer	3.57e-06	6.39e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GSTM1—breast cancer	3.57e-06	6.39e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.54e-06	6.34e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—COMT—breast cancer	3.5e-06	6.27e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTP1—breast cancer	3.49e-06	6.24e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NCOA1—breast cancer	3.49e-06	6.24e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CAV1—breast cancer	3.46e-06	6.19e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—HMOX1—breast cancer	3.44e-06	6.16e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GPX1—breast cancer	3.44e-06	6.16e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—STK11—breast cancer	3.44e-06	6.15e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP19A1—breast cancer	3.44e-06	6.15e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ITPR1—breast cancer	3.43e-06	6.14e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—DPYD—breast cancer	3.42e-06	6.13e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MED12—breast cancer	3.42e-06	6.13e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GPX1—breast cancer	3.42e-06	6.12e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP1A1—breast cancer	3.4e-06	6.09e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP1A1—breast cancer	3.38e-06	6.06e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ERCC2—breast cancer	3.37e-06	6.04e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALDOA—breast cancer	3.37e-06	6.03e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—ERCC2—breast cancer	3.36e-06	6.01e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—KRAS—breast cancer	3.32e-06	5.95e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ABCB1—breast cancer	3.3e-06	5.91e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOA3—breast cancer	3.27e-06	5.86e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC2A2—breast cancer	3.25e-06	5.81e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—TYMS—breast cancer	3.24e-06	5.81e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.22e-06	5.78e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.2e-06	5.74e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GSTM1—breast cancer	3.2e-06	5.74e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NCOR1—breast cancer	3.2e-06	5.74e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—COMT—breast cancer	3.19e-06	5.72e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CPT1A—breast cancer	3.18e-06	5.7e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MTR—breast cancer	3.18e-06	5.7e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCG2—breast cancer	3.18e-06	5.7e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTP1—breast cancer	3.18e-06	5.69e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—MTHFR—breast cancer	3.17e-06	5.68e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—MTHFR—breast cancer	3.15e-06	5.65e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CG—breast cancer	3.15e-06	5.64e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—HMOX1—breast cancer	3.13e-06	5.62e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ITPR1—breast cancer	3.13e-06	5.6e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HPGDS—breast cancer	3.12e-06	5.59e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HBA1—breast cancer	3.1e-06	5.55e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GPX1—breast cancer	3.07e-06	5.5e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PIK3CA—breast cancer	3.05e-06	5.47e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP1A1—breast cancer	3.04e-06	5.44e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTT1—breast cancer	3.02e-06	5.42e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ACHE—breast cancer	3.02e-06	5.42e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ERCC2—breast cancer	3.01e-06	5.4e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ABCB1—breast cancer	3.01e-06	5.39e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—TYMS—breast cancer	2.96e-06	5.29e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TP53—breast cancer	2.95e-06	5.29e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CAV1—breast cancer	2.93e-06	5.24e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.92e-06	5.23e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GSTM1—breast cancer	2.92e-06	5.23e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NCOR1—breast cancer	2.92e-06	5.23e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CAV1—breast cancer	2.91e-06	5.21e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP17A1—breast cancer	2.86e-06	5.13e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTGS1—breast cancer	2.83e-06	5.08e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ENO1—breast cancer	2.83e-06	5.08e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—MTHFR—breast cancer	2.83e-06	5.07e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—HRAS—breast cancer	2.82e-06	5.06e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GPX1—breast cancer	2.8e-06	5.01e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.8e-06	5.01e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.78e-06	4.98e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP2D6—breast cancer	2.78e-06	4.98e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP1A1—breast cancer	2.77e-06	4.96e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CD—breast cancer	2.77e-06	4.96e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ERCC2—breast cancer	2.75e-06	4.92e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ALB—breast cancer	2.73e-06	4.89e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOA2—breast cancer	2.73e-06	4.89e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CG—breast cancer	2.67e-06	4.77e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CG—breast cancer	2.65e-06	4.75e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—FASN—breast cancer	2.65e-06	4.74e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—BCHE—breast cancer	2.63e-06	4.72e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—NOS3—breast cancer	2.61e-06	4.68e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CAV1—breast cancer	2.61e-06	4.68e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC5A5—breast cancer	2.6e-06	4.66e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—MTHFR—breast cancer	2.58e-06	4.62e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NQO1—breast cancer	2.51e-06	4.5e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SLC2A1—breast cancer	2.51e-06	4.5e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.5e-06	4.47e-05	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—AKT1—breast cancer	2.49e-06	4.47e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CB—breast cancer	2.41e-06	4.32e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP1B1—breast cancer	2.41e-06	4.32e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTGS2—breast cancer	2.39e-06	4.28e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CAV1—breast cancer	2.38e-06	4.27e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CG—breast cancer	2.38e-06	4.26e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.36e-06	4.23e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CD—breast cancer	2.34e-06	4.2e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CD—breast cancer	2.33e-06	4.17e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALB—breast cancer	2.31e-06	4.14e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOA1—breast cancer	2.3e-06	4.12e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.27e-06	4.08e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP19A1—breast cancer	2.27e-06	4.06e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—STK11—breast cancer	2.27e-06	4.06e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—NOS3—breast cancer	2.21e-06	3.96e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—NOS3—breast cancer	2.2e-06	3.94e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CG—breast cancer	2.17e-06	3.89e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—COMT—breast cancer	2.11e-06	3.77e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTP1—breast cancer	2.1e-06	3.76e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CD—breast cancer	2.09e-06	3.75e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PTEN—breast cancer	2.08e-06	3.73e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—HMOX1—breast cancer	2.07e-06	3.7e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALB—breast cancer	2.06e-06	3.7e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ITPR1—breast cancer	2.06e-06	3.7e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CB—breast cancer	2.04e-06	3.66e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CB—breast cancer	2.03e-06	3.64e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTGS2—breast cancer	2.02e-06	3.62e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTGS2—breast cancer	2.01e-06	3.6e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ABCB1—breast cancer	1.98e-06	3.55e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—NOS3—breast cancer	1.97e-06	3.54e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—TYMS—breast cancer	1.95e-06	3.49e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NCOR1—breast cancer	1.93e-06	3.45e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.93e-06	3.45e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GSTM1—breast cancer	1.93e-06	3.45e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CD—breast cancer	1.91e-06	3.42e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALB—breast cancer	1.88e-06	3.37e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GPX1—breast cancer	1.84e-06	3.3e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP1A1—breast cancer	1.83e-06	3.27e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CB—breast cancer	1.82e-06	3.27e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ERCC2—breast cancer	1.81e-06	3.24e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTGS2—breast cancer	1.81e-06	3.24e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—NOS3—breast cancer	1.8e-06	3.23e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PTEN—breast cancer	1.76e-06	3.16e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PTEN—breast cancer	1.75e-06	3.14e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—MTHFR—breast cancer	1.7e-06	3.05e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CB—breast cancer	1.66e-06	2.98e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTGS2—breast cancer	1.65e-06	2.95e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PTEN—breast cancer	1.58e-06	2.82e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CAV1—breast cancer	1.57e-06	2.81e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—PIK3CA—breast cancer	1.47e-06	2.63e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PTEN—breast cancer	1.44e-06	2.57e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CG—breast cancer	1.43e-06	2.56e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CD—breast cancer	1.26e-06	2.25e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—PIK3CA—breast cancer	1.24e-06	2.23e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALB—breast cancer	1.24e-06	2.22e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—PIK3CA—breast cancer	1.24e-06	2.22e-05	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—AKT1—breast cancer	1.2e-06	2.15e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—NOS3—breast cancer	1.19e-06	2.13e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—PIK3CA—breast cancer	1.11e-06	1.99e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CB—breast cancer	1.1e-06	1.96e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTGS2—breast cancer	1.09e-06	1.95e-05	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—AKT1—breast cancer	1.02e-06	1.82e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—PIK3CA—breast cancer	1.01e-06	1.81e-05	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—AKT1—breast cancer	1.01e-06	1.81e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PTEN—breast cancer	9.47e-07	1.7e-05	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—AKT1—breast cancer	9.08e-07	1.63e-05	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—AKT1—breast cancer	8.28e-07	1.48e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—PIK3CA—breast cancer	6.68e-07	1.2e-05	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—AKT1—breast cancer	5.46e-07	9.78e-06	CbGpPWpGaD
